Acute arrhythmogenicity of first-dose chemotherapeutic agents in children

Medical and Pediatric Oncology

Volumn 39, Issue 2, 2002, Pages 93-98

  Massin, Martial M ^a   Dresse, Marie Françoise ^a   Schmitz, Véronique ^a   Hoyoux, Claire ^a   Chantraine, Jean Marie ^a   Lepage, Philippe ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Arrhythmias; Cardiotoxicity; Chemotherapeutic agents; Childhood cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ARTICLE; ATRIOVENTRICULAR BLOCK; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HEART ARRHYTHMIA; HEART CONDUCTION; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; INFANT; LEUKEMIA; LYMPHOMA; MALE; NEPHROBLASTOMA; PRIORITY JOURNAL; SINUS NODE; SUPRAVENTRICULAR PREMATURE BEAT;

ACUTE DISEASE; ADOLESCENT; ANTINEOPLASTIC AGENTS; ARRHYTHMIA; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; INFANT; MALE; NEOPLASMS; PROGNOSIS; RESEARCH DESIGN; RISK FACTORS;

EID: 0036291873     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10123     Document Type: Article

References (16)

1. Cardiotoxicity of chemotherapeutic agents
2. Phase II evaluation of adriamycin in human neoplasm
3. Sudden death during doxorubicin administration
4. Cardiovascular toxicity with cancer therapy
5. Adriamycin cardiomyopathy - An overview with determination of risk factors
6. Adriamycin cardiotoxicity: Possible pathogenic mechanisms
7. The effects of adriamycin on normal and ouabain-toxic canine purkinje and ventricular muscle fibers
8. Adriamycin-induced alterations of the action potential in rat papillary muscle
9. Acute arrhythmogenicity of doxorubicin administration
10. Effects of first-dose doxorubicin on cardiac rhythm as evaluated by continuous 24-hour monitoring
11. Early cardiac toxicity of 4′iodo-4′-deoxydoxorubicin
12. Cyclophosphamide cardiotoxicity: An analysis of dosing as a risk factor
13. High-dose cyclophosphamide-induced myocardial damage during BMT: Assessment by positron emission tomography
14. Vindesine associated angina and ECG changes
15. Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation
16. Heart rate and heart rhythm in healthy infants and children